Literature DB >> 18212647

Early coagulopathy after traumatic brain injury: the role of hypoperfusion and the protein C pathway.

Mitchell Jay Cohen1, Karim Brohi, Michael T Ganter, Geoffrey T Manley, Robert C Mackersie, Jean-François Pittet.   

Abstract

INTRODUCTION: Early coagulopathy after traumatic brain injury (TBI) is thought to be the result of injury-mediated local release of tissue factor, although the precise mechanisms that cause hypoperfusion and early systemic coagulopathy in TBI patients are unknown. We have previously reported that early systemic coagulopathy after trauma is present only when tissue injury is associated with severe hypoperfusion leading to the activation of the protein C pathway. However, the role of hypoperfusion as an important mechanism for the development of coagulopathy early after TBI is unclear. The objective of the present study was to determine the importance of hypoperfusion and protein C activation in causing early coagulopathy in TBI patients. MATERIALS: We performed a prospective cohort study including patients with isolated brain injury admitted to a single trauma center. Blood was drawn on average 32 minutes after injury. Plasma samples were assayed for protein C and thrombomodulin by standard laboratory techniques. Routine coagulation measures (prothrombin time, partial thromboplastin time) and arterial blood gas analysis were performed concurrently. Severe hypoperfusion was evidenced by the presence of an arterial base deficit greater than 6.
RESULTS: Thirty-nine TBI patients were included in the study during a 15-month period. TBI patients without concurrent hypoperfusion (n = 28) did not develop an early coagulopathy after trauma, no matter the severity of injury. In contrast, patients with TBI who also had severe hypoperfusion (BD >6) (n = 11) were coagulopathic early after injury. Indeed, these patients had higher prothrombin time and partial thromboplastin time, compared with those with TBI and a BD <6 (17.6 +/- 3.6 vs. 14.3 +/- 2.3, p < 0.005; and 43.13 +/- 18.3 vs. 27.4 +/- 3.8, p < 0.0001). Unactivated protein C levels were lower in the TBI group with BD >6 (56 +/- 32 vs. 85 +/- 35, p = 0.03) and thrombomodulin levels were significantly higher (48 +/- 26 vs. 35 +/- 10, p = 0.04). Without hypoperfusion, there was no effect of increasing brain injury on protein C pathway or fibrinolysis pathway mediators.
CONCLUSIONS: TBI alone does not cause early coagulopathy, but must be coupled with hypoperfusion to lead to coagulation derangements, associated with the activation of the protein C pathway. This novel finding has significant implications for the treatment of coagulopathy after severe brain injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18212647     DOI: 10.1097/TA.0b013e318156ee4c

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  57 in total

1.  Severe leukoaraiosis portends a poor outcome after traumatic brain injury.

Authors:  Nils Henninger; Saef Izzy; Raphael Carandang; Wiley Hall; Susanne Muehlschlegel
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

Review 2.  Acute Management of Traumatic Brain Injury.

Authors:  Michael A Vella; Marie L Crandall; Mayur B Patel
Journal:  Surg Clin North Am       Date:  2017-10       Impact factor: 2.741

Review 3.  Intracranial hemorrhage: mechanisms of secondary brain injury.

Authors:  Josephine Lok; Wendy Leung; Sarah Murphy; William Butler; Natan Noviski; Eng H Lo
Journal:  Acta Neurochir Suppl       Date:  2011

4.  Thromboelastography defines late hypercoagulability after TBI: a pilot study.

Authors:  Allie M Massaro; Sean Doerfler; Kelsey Nawalinski; Bernard Michel; Nicolette Driscoll; Connie Ju; Hiren Patel; Francis Quattrone; Suzanne Frangos; Eileen Maloney-Wilensky; Michael Sean Grady; Sherman C Stein; Scott E Kasner; Monisha A Kumar
Journal:  Neurocrit Care       Date:  2015-02       Impact factor: 3.210

5.  Severe traumatic brain injury is associated with a unique coagulopathy phenotype.

Authors:  Jason M Samuels; Ernest E Moore; Christopher C Silliman; Anirban Banerjee; Mitchell J Cohen; Arsen Ghasabyan; James Chandler; Julia R Coleman; Angela Sauaia
Journal:  J Trauma Acute Care Surg       Date:  2019-04       Impact factor: 3.313

Review 6.  Coagulopathy associated with traumatic brain injury.

Authors:  Monisha A Kumar
Journal:  Curr Neurol Neurosci Rep       Date:  2013-11       Impact factor: 5.081

7.  Platelet dysfunction is an early marker for traumatic brain injury-induced coagulopathy.

Authors:  Patrick K Davis; Harsha Musunuru; Mark Walsh; Robert Cassady; Robert Yount; Andrew Losiniecki; Ernest E Moore; Max V Wohlauer; Janet Howard; Victoria A Ploplis; Francis J Castellino; Scott G Thomas
Journal:  Neurocrit Care       Date:  2013-04       Impact factor: 3.210

8.  Early coagulation events induce acute lung injury in a rat model of blunt traumatic brain injury.

Authors:  Hideki Yasui; Deborah L Donahue; Mark Walsh; Francis J Castellino; Victoria A Ploplis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-05-17       Impact factor: 5.464

Review 9.  Transfusion management of trauma patients.

Authors:  Beth H Shaz; Christopher J Dente; Robert S Harris; Jana B MacLeod; Christopher D Hillyer
Journal:  Anesth Analg       Date:  2009-06       Impact factor: 5.108

Review 10.  Fibrinogen metabolic responses to trauma.

Authors:  Wenjun Zhou Martini
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2009-01-13       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.